EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,896 | -59.5% | 32,430 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $26,884 | -7.6% | 32,430 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $29,086 | -32.1% | 32,430 | 0.0% | 0.00% | -57.1% |
| Q4 2022 | $42,808 | -74.1% | 32,430 | 0.0% | 0.01% | -90.0% |
| Q3 2022 | $165,000 | -37.5% | 32,430 | 0.0% | 0.07% | -39.1% |
| Q2 2022 | $264,000 | +24.5% | 32,430 | 0.0% | 0.12% | +38.6% |
| Q1 2022 | $212,000 | +57.0% | 32,430 | 0.0% | 0.08% | +48.2% |
| Q4 2021 | $135,000 | -38.4% | 32,430 | 0.0% | 0.06% | -32.5% |
| Q3 2021 | $219,000 | -18.6% | 32,430 | 0.0% | 0.08% | -18.6% |
| Q2 2021 | $269,000 | -7.2% | 32,430 | 0.0% | 0.10% | -17.7% |
| Q1 2021 | $290,000 | -23.5% | 32,430 | 0.0% | 0.12% | -28.7% |
| Q4 2020 | $379,000 | – | 32,430 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
| NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
| RA Capital Management | 354,200 | $4,056,000 | 0.50% |
| DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
| Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
| Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
| Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |